in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Aurobindo to acquire Hyacinths Pharma as part of APIs push
7:19 AM MDT | September 13, 2013 | Natasha Alperowicz
Aurobindo Pharma (Hyderabad, India) says it will acquire, from existing private shareholders, Hyacinths Pharma (Andhra Pradesh, India), a company incorporated to manufacture active pharmaceutical ingredients (APIs). Hyacinths, located near Aurobindo’s operations, has a 53-acre site at Srikakulum, India—also near Aurobindo—and all the necessary approvals to begin production of APIs. The acquisition forms part of Aurobindo’s previously announced plan to raise sales of APIs to $700 million by fiscal 2016. In fiscal 2013, the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee